Biobank Cardiac Surgery
Biobank of Blood and Tissue Samples From Patients Undergoing Cardiac Surgery
University of Chicago
500 participants
Dec 18, 2023
OBSERVATIONAL
Conditions
Summary
Treatment strategies for cardiac surgery patients have been evolving significantly for the last decade. While clinical outcomes have been improving, there are still significant areas unexplored in these patients. Cardiac surgery, or cardiovascular surgery, is surgery on the heart or great vessels performed by cardiac surgeons. It is often used to treat complications of ischemic heart disease (for example, with coronary artery bypass grafting); to correct congenital heart disease; or to treat valvular heart disease from various causes, including endocarditis, rheumatic heart disease, and atherosclerosis. Biobanking is a fundamental process required in the better understanding of human diseases together with their underlying mechanisms. Biobanking refers to the process by which samples of bodily fluid or tissue are collected for research use to improve the understanding of health and disease. For this study, the investigator's objective is to acquire elucidation in disease etiology, translation, and advancing public health by evaluating blood and tissue results of those with cardiac disease undergoing cardiac surgery.
Eligibility
Inclusion Criteria2
- All patients who undergo cardiac surgery at Advocate Children's Hospital (ACH)\& University of Chicago Medical Center (UCMC) by the ACH \& UC Cardiothoracic Surgery Research team who are pediatric neonates and up.
- Patients will only be English speaking.
Exclusion Criteria1
- Vulnerable Subjects/Subject Capacity to provide consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
To assess blood and tissue biomarkers of patients undergoing cardiac surgery
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06747806